Hong Jing

发表

XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy

Yu-Long He, X. Ren, Changjiang Qin, 2015, Oncotarget.

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells

Xiaoliang Wang, Changjiang Qin, Kaiwu Xu, 2022, Cell death & disease.

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells

Xiaoliang Wang, Yi-jie Zhang, Changjiang Qin, 2021, Cell Death & Disease.

Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF‐κB and p53

Shouming Xu, Hong Jing, Gui-Li Huang, 2018, Journal of cellular biochemistry.

Expression and prognosis analysis of JMJD5 in human cancers.

Hui Zhang, Z. Suo, Hui Li, 2020, Frontiers in bioscience.

Increased DHRS12 expression independently predicts poor survival in patients with high-grade serous ovarian cancer.

Hong Jing, Gui-Li Huang, Jiang Wu, 2018, Future oncology.

Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.

Hong Jing, Gui-Li Huang, Zhu-lei Sun, 2015, International journal of clinical and experimental pathology.

The diagnostic and prognostic value of CHFR hypermethylation in colorectal cancer, a meta-analysis and literature review

Jiang Wu, Hong Jing, Zhu-lei Sun, 2017, OncoTarget.

MiR-886-5p inhibition inhibits growth and induces apoptosis of MCF7 cells.

Yan Zhang, Hong Jing, Zhu-lei Sun, 2014, Asian Pacific journal of cancer prevention : APJCP.

MiR-886-5 p Inhibition Inhibits Growth and Induces Apoptosis of MCF 7 Cells

Yan Zhang, Hong Jing, Zhu-lei Sun, 2014 .